Ultrasound evaluation of fetal nasal bone at 11 to 14 weeks in a consecutive series of 1906 fetuses

被引:53
作者
Viora, E [1 ]
Masturzo, B [1 ]
Errante, G [1 ]
Sciarrone, A [1 ]
Bastonero, S [1 ]
Campogrande, M [1 ]
机构
[1] Osped Sant Anna, Ctr Ecog & Diag Prenatale, Ultrasound & Prenatal Diag Unit, I-10126 Turin, Italy
关键词
prenatal screening; Down syndrome; nasal bone;
D O I
10.1002/pd.694
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective The aim of this study is to evaluate the significance of nasal bone ossification as a marker for trisomy 21 at 11 to 14 weeks' gestation in an unselected obstetric population referred to our Centre. Methods A total of 1906 consecutive fetuses undergoing nuchal translucency scan at 11 to 14 weeks' gestation were evaluated for the presence of hypoplasia/absence of nasal bone. The data obtained were correlated with fetal karyotype. Results A successful view of the fetal profile was obtained in 1752 fetuses (91.9%). The nasal bone was hypoplastic/absent in 12 of 19 fetuses with chromosomal abnormalities. There were 10 cases of trisomy 21, in 8 of which hypoplastic/absent nasal bone was observed. Furthermore, absence of nasal bone was recorded in 24 of 1733 chromosomally normal fetuses. Conclusions Nasal bone evaluation may improve the detection of trisomy 21 in the first trimester in an unselected obstetric population. Although numerically limited, our experience confirms that delayed nasal bone ossification (hypoplasia/absence of nasal bone) is rarely observed in chromosomally normal fetuses (1.4%). An appropriate training of operators is mandatory in order to achieve an acceptable performance. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:784 / 787
页数:4
相关论文
共 9 条
[1]   Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free β-hCG and PAPP-A at 11 to 14 weeks [J].
Cicero, S ;
Bindra, R ;
Rembouskos, G ;
Spencer, K ;
Nicolaides, KH .
PRENATAL DIAGNOSIS, 2003, 23 (04) :306-310
[2]  
Cicero S, 2002, J Matern Fetal Neonatal Med, V11, P400, DOI 10.1080/713605572
[3]   Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study [J].
Cicero, S ;
Curcio, P ;
Papageorghiou, A ;
Sonek, J ;
Nicolaides, K .
LANCET, 2001, 358 (9294) :1665-1667
[4]   Absence of nasal bone and detection of trisomy 21 - Reply [J].
Cuckle, H .
LANCET, 2002, 359 (9314) :1345-1345
[5]   Time for total shift to first-trimester screening for Down's syndrome [J].
Cuckle, H .
LANCET, 2001, 358 (9294) :1658-1659
[6]  
Monni G, 2002, LANCET, V359, P1343, DOI 10.1016/S0140-6736(02)08287-9
[7]   Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment [J].
Orlandi, F ;
Bilardo, CM ;
Campogrande, M ;
Krantz, D ;
Hallahan, T ;
Rossi, C ;
Viora, E .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2003, 22 (01) :36-39
[8]   Association between first trimester absence of fetal nasal bone on ultrasound and Down syndrome [J].
Otaño, L ;
Aiello, H ;
Igarzábal, L ;
Matayoshi, T ;
Gadow, EC .
PRENATAL DIAGNOSIS, 2002, 22 (10) :930-932
[9]  
Reynolds TM, 2002, LANCET, V359, P1344, DOI 10.1016/S0140-6736(02)08290-9